Serologic response to rickettsial antigens in patients with Astrakhan fever

M E Eremeeva1, N M Balayeva, V F Ignatovich

  • 1Unité des Rickettsies, CNRS EP J 0054, Faculté de Medicine, Marseille, France.

Insights

Astrakhan fever, a spotted fever group rickettsiosis, elicits a distinct serologic response. Antibodies detected primarily target lipopolysaccharide, differentiating it from R. conorii infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Astrakhan fever is an emerging rickettsiosis within the spotted fever group (SFG).
  • Understanding the serological profile of Astrakhan fever is crucial for accurate diagnosis and differentiating it from other SFG rickettsioses.

Purpose of the Study:

  • To characterize the serologic responses in patients with Astrakhan fever.
  • To compare the immune response to the Astrakhan strain with other SFG rickettsiae, specifically R. conorii and an Israeli isolate.

Main Methods:

  • Microimmunofluorescence and western immunoblotting techniques were employed.
  • Patient sera were tested against the Astrakhan strain, R. conorii M-1, and an Israeli SFG rickettsiae isolate.

Main Results:

  • Serologic responses to the Astrakhan strain and the Israeli isolate were similar but distinct from R. conorii.
  • Immunoglobulin G (IgG) and IgM antibodies were prevalent, predominantly targeting lipopolysaccharide.
  • A minority of sera showed IgG antibodies recognizing high molecular weight proteins.

Conclusions:

  • Astrakhan fever demonstrates a unique serologic signature.
  • The findings aid in distinguishing Astrakhan fever from other SFG rickettsioses based on antibody profiles.